Market Research Logo

IntegraGen SA (ALINT) - Product Pipeline Analysis, 2017 Update

Summary

IntegraGen SA (IntegraGen) is a biotechnology company that offers clinical genomic services to academic researchers and life sciences companies. The company provides advanced bioinformatics and biostatistical analytical tools and services. Its genomic services include clinical research, basic and human genetic research, bioinformatics and bioanalysis, agrigenomics and microbial genomics, among others. IntegraGen also offers DNA extraction, management samples, study design, strategy, selection markers, tagging, biostatistics analysis and bioinformatics analysis of sequence data services, among others. The company offers services in the fields of pharmacogenetics, cytogenetics, epigenetics and agriculture. It serves patients, clinicians and researchers. The company has its presence in France and the US. IntegraGen is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company IntegraGen SA
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


IntegraGen SA Company Overview
IntegraGen SA Company Snapshot
IntegraGen SA Pipeline Products and Ongoing Clinical Trials Overview
IntegraGen SA – Pipeline Analysis Overview
IntegraGen SA - Key Facts
IntegraGen SA - Major Products and Services
IntegraGen SA Pipeline Products by Development Stage
IntegraGen SA Pipeline Products Overview
Biomarker-Based Diagnostic Test - hsa-miR-31-3p - Lung Cancer
Biomarker-Based Diagnostic Test - hsa-miR-31-3p - Lung Cancer Product Overview
Diagnostic Test - Hepatocellular Carcinoma
Diagnostic Test - Hepatocellular Carcinoma Product Overview
Laboratory Developed Test - hsa-miR-31-3p - Lung Cancer
Laboratory Developed Test - hsa-miR-31-3p - Lung Cancer Product Overview
miRpredX 31-3p - Colorectal Cancer
miRpredX 31-3p - Colorectal Cancer Product Overview
IntegraGen SA - Key Competitors
IntegraGen SA - Key Employees
IntegraGen SA - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
IntegraGen SA, Recent Developments
Jul 11, 2017: Integragen Reports Continued Growth During 1st Half Of 2017
Apr 21, 2017: IntegraGen Announces 2016 Annual Results: Increase in operating revenues and significant improvement in operating income (+22%)
Jan 09, 2017: IntegraGen Reports Sharp Increase in Sales During 2016
Oct 14, 2016: IntegraGen Reports Revenues for First Half of 2016
Sep 14, 2016: New data on miR-31-3p biomarker to be featured during oral presentation at 2016 ESMO Congress
Jul 07, 2016: IntegraGen reports strong revenue growth during first half of 2016
Jan 14, 2016: IntegraGen Reports 2015 Revenues
Feb 05, 2015: IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test
Feb 05, 2015: IntegraGen Announces Distribution Agreement for Autism Risk Assessment Test
May 19, 2014: IntegraGen Presents Data on New Version of the ARISk Test during the 13th Annual Meeting for Autism Research
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
IntegraGen SA Pipeline Products and Ongoing Clinical Trials Overview
IntegraGen SA Pipeline Products by Equipment Type
IntegraGen SA Pipeline Products by Indication
IntegraGen SA, Key Facts
IntegraGen SA, Major Products and Services
IntegraGen SA Number of Pipeline Products by Development Stage
IntegraGen SA Pipeline Products Summary by Development Stage
Biomarker-Based Diagnostic Test - hsa-miR-31-3p - Lung Cancer - Product Status
Biomarker-Based Diagnostic Test - hsa-miR-31-3p - Lung Cancer - Product Description
Diagnostic Test - Hepatocellular Carcinoma - Product Status
Diagnostic Test - Hepatocellular Carcinoma - Product Description
Laboratory Developed Test - hsa-miR-31-3p - Lung Cancer - Product Status
Laboratory Developed Test - hsa-miR-31-3p - Lung Cancer - Product Description
miRpredX 31-3p - Colorectal Cancer - Product Status
miRpredX 31-3p - Colorectal Cancer - Product Description
IntegraGen SA, Key Employees
IntegraGen SA, Subsidiaries
Glossary
List of Figures
IntegraGen SA Pipeline Products by Equipment Type
IntegraGen SA Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report